From Label to Etiology: Applying the 2026 AACE Framework

Experts conclude by emphasizing that the 2026 AACE classification algorithm is a call for clinicians to pause, reassess presumed type 2 diabetes, and recognize that getting the etiology right is foundational to optimizing downstream treatment.

In the closing segment, Samson reiterates that the differential diagnosis for adult-onset diabetes is far broader than the traditional assumption that most patients have type 2 diabetes. She emphasizes that clinicians should not simply accept a preexisting type 2 diabetes label when patients establish care, particularly if the disease course does not align with the expected phenotype. Instead, the 2026 AACE algorithm encourages a systematic reassessment of diagnosis when glycemic patterns, insulin requirements, weight trajectory, or associated comorbidities raise concern.

Samson notes that individuals who clearly do not fit a typical type 2 phenotype—whether because of autoimmunity, pancreatic disease, endocrinopathy, or genetic features—should be referred for endocrinology evaluation and more detailed classification.

Umpierrez reflects on his decades of practice in diabetes and endocrinology and candidly acknowledges how often he now questions whether earlier patients may have been misclassified as having type 2 diabetes. He underscores that misclassification of adult-onset type 1 diabetes as type 2, pancreatic diabetes, MODY, or cortisol-mediated diabetes is not merely academic; it can profoundly alter downstream treatment decisions, risk for acute complications such as diabetic ketoacidosis, and the trajectory of chronic complications.

In his view, the 2026 AACE classification algorithm provides a practical, clinically oriented framework that can help busy clinicians recognize when additional testing, imaging, or specialist referral is warranted.

Together, Samson and Umpierrez characterize the new algorithm as an “invitation to pause”—a structured prompt to ask whether the current diagnosis truly explains the patient’s presentation and treatment response. By embedding classification logic alongside therapeutic guidance, the 2026 AACE algorithm aims to ensure that the right diagnosis underpins decisions about pharmacologic therapy, technology use, and long-term risk reduction.

The experts conclude that widespread adoption of this approach has the potential to improve diagnostic accuracy, individualize care, and ultimately enhance outcomes for adults living with diabetes who might otherwise be managed under an oversimplified label of type 2 diabetes.